Rodos BioTarget (RBT), a Germany-based drug delivery company, has raised €2.6m ($3.5m) from a consortium including InvestImpuls-Fonds of the region of Hannover (Germany) under the management of EnjoyVenture and the corporate and state-backed early-stage investment firm High-Tech Gründerfonds and the KfW’s ERP Start Fund.
In addition to institutional investors, RBT said it attracted family office and business angels, “which is an as an encouraging signal for the German biotech industry as a whole”.
In 2008, RBT raised start-up financing from the High-Tech Gründerfonds (HTGF) and the Hannover Innovation Fund (hif), with equity added last year.